![Life | Free Full-Text | Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases Life | Free Full-Text | Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases](https://www.mdpi.com/life/life-11-00581/article_deploy/html/images/life-11-00581-g001.png)
Life | Free Full-Text | Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases
![Diagnostic value of apolipoprotein A1 in neonatal sepsis El-Gendy FM, El-Lahony DM, R. Midan DA, Amin Shaban WM - Menoufia Med J Diagnostic value of apolipoprotein A1 in neonatal sepsis El-Gendy FM, El-Lahony DM, R. Midan DA, Amin Shaban WM - Menoufia Med J](https://www.mmj.eg.net/articles/2018/31/3/images/MenoufiaMedJ_2018_31_3_1011_248730_t8.jpg)
Diagnostic value of apolipoprotein A1 in neonatal sepsis El-Gendy FM, El-Lahony DM, R. Midan DA, Amin Shaban WM - Menoufia Med J
![Pharmaceuticals | Free Full-Text | Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies Pharmaceuticals | Free Full-Text | Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-01278/article_deploy/html/images/pharmaceuticals-15-01278-g001.png?1666341942)
Pharmaceuticals | Free Full-Text | Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy | PLOS ONE
![Antiatherosclerotic Effects of 1-Methylnicotinamide in Apolipoprotein E/Low-Density Lipoprotein Receptor–Deficient Mice: A Comparison with Nicotinic Acid | Journal of Pharmacology and Experimental Therapeutics Antiatherosclerotic Effects of 1-Methylnicotinamide in Apolipoprotein E/Low-Density Lipoprotein Receptor–Deficient Mice: A Comparison with Nicotinic Acid | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/356/2/514/F1.large.jpg)
Antiatherosclerotic Effects of 1-Methylnicotinamide in Apolipoprotein E/Low-Density Lipoprotein Receptor–Deficient Mice: A Comparison with Nicotinic Acid | Journal of Pharmacology and Experimental Therapeutics
![Biomedicines | Free Full-Text | High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression? Biomedicines | Free Full-Text | High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?](https://www.mdpi.com/biomedicines/biomedicines-08-00549/article_deploy/html/images/biomedicines-08-00549-g001.png)
Biomedicines | Free Full-Text | High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?
![Serum Apolipoprotein B and A1 Concentrations Predict Late-Onset Posttransplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients - Rohit Malyala, Lindita Rapi, Michelle M. Nash, G. V. Ramesh Prasad, 2019 Serum Apolipoprotein B and A1 Concentrations Predict Late-Onset Posttransplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients - Rohit Malyala, Lindita Rapi, Michelle M. Nash, G. V. Ramesh Prasad, 2019](https://journals.sagepub.com/cms/10.1177/2054358119850536/asset/images/large/10.1177_2054358119850536-fig2.jpeg)